MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 6, 2004; DOI: 10.1124/mol.104.002857


0026-895X/05/6701-50-59$20.00
Mol Pharmacol 67:50-59, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002857v1
67/1/50    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapinsh, M.
Right arrow Articles by Wikberg, J. E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapinsh, M.
Right arrow Articles by Wikberg, J. E. S.

Proteochemometric Mapping of the Interaction of Organic Compounds with Melanocortin Receptor Subtypes

Maris Lapinsh, Santa Veiksina, Staffan Uhlén, Ramona Petrovska, Ilze Mutule, Felikss Mutulis, Sviatlana Yahorava, Peteris Prusis, and Jarl E. S. Wikberg

Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

Proteochemometrics was applied in the analysis of the binding of organic compounds to wild-type and chimeric melanocortin receptors. Thirteen chimeric melanocortin receptors were designed based on statistical molecular design; each chimera contained parts from three of the MC1,3-5 receptors. The binding affinities of 18 compounds were determined for these chimeric melanocortin receptors and the four wild-type melanocortin receptors. The data for 14 of these compounds were correlated to the physicochemical and structural descriptors of compounds, binary descriptors of receptor sequences, and cross-terms derived from ligand and receptor descriptors to obtain a proteochemometric model (correlation was performed using partial least-squares projections to latent structures; PLS). A well fitted mathematical model (R2 = 0.92) with high predictive ability (Q2 = 0.79) was obtained. In a further validation of the model, the predictive ability for ligands (Q2lig = 0.68) and receptors (Q2rec = 0.76) was estimated. The model was moreover validated by external prediction by using the data for the four additional compounds that had not at all been included in the proteochemometric model; the analysis yielded a Q2ext = 0.73. An interpretation of the results using PLS coefficients revealed the influence of particular properties of organic compounds on their affinity to melanocortin receptors. Three-dimensional models of melanocortin receptors were also created, and physicochemical properties of the amino acids inside the receptors' transmembrane cavity were correlated to the PLS modeling results. The importance of particular amino acids for selective binding of organic compounds was estimated and used to outline the ligand recognition site in the melanocortin receptors.


Received May 16, 2004; accepted September 27, 2004

Address correspondence to: Dr. Jarl Wikberg, Pharmaceutical Pharmacology, Box 591, BMC, SE751 24 Uppsala, Sweden. E-mail: jarl.wikberg{at}farmbio.uu.se




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
W. K. Kroeze and B. L. Roth
Screening the receptorome.
J Psychopharmacol, July 1, 2006; 20(4 Suppl): 41 - 46.
[Abstract] [PDF]


Home page
BioinformaticsHome page
M. Lapinsh, P. Prusis, S. Uhlen, and J. E. S. Wikberg
Improved approach for proteochemometrics modeling: application to organic compound--amine G protein-coupled receptor interactions
Bioinformatics, December 1, 2005; 21(23): 4289 - 4296.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics